Medtronic Acquires Cardiocom Integrated Telehealth Provider
|
By HospiMedica International staff writers Posted on 19 Aug 2013 |
Medtronic (Minneapolis, MN, USA) has acquired Cardiocom (Chanhassen, MN, USA), a maker of remote management technology, strengthening its position in the high-growth market for telehealth products.
The all-cash transaction, valued at USD 200 million, is in line with Medtronic's transition towards an expanded medical device product offering and broader healthcare services and solutions, providing meaningful clinical and economic value for hospitals, physicians, patients and payers. The first area of focus for Medtronic will be in heart failure (HF), where the addition of the Cardiocom technology and patient services to its product offerings will expand its reach to more patients across the HF care continuum. Cardiocom also has products for the management of diabetes, cardiovascular disease, and hypertension.
For Medtronic, a company with a lot of investment in the high cost and shrinking-demand market for cardiac rhythm management (CRM) devices, the entrance into patient monitoring is a bid for diversification, helping the company combine diagnostics, therapies, and patient management technologies reporting real-time data back to physicians and nurses. Medtronic has stated that at-home monitoring is a proven method of reducing the rates of hospital readmission, with resulting savings for payers, providers, and governments.
“With broad healthcare reform initiatives focused on growing economic challenges, healthcare systems in every region of the world are striving to continuously improve outcomes, increase access, save cost, and improve the efficiency of healthcare delivery,” said Omar Ishrak, chairman and CEO of Medtronic. “The acquisition of Cardiocom is one step we are taking toward providing a combination of products and solutions that can help address those challenges.”
“The synergy between our technologies and Medtronic's large presence with hospitals, physicians, and payers will dramatically increase our distribution channels for the Cardiocom patient management technologies and services,” said Daniel Cosentino, vice president and general manager of Cardiocom at Medtronic, and former CEO of Cardiocom. “Our approach to care coordination and telehealth services has allowed customers to reduce the overall cost of care, primarily through reduced hospitalizations.”
Related Links:
Medtronic
Cardiocom
The all-cash transaction, valued at USD 200 million, is in line with Medtronic's transition towards an expanded medical device product offering and broader healthcare services and solutions, providing meaningful clinical and economic value for hospitals, physicians, patients and payers. The first area of focus for Medtronic will be in heart failure (HF), where the addition of the Cardiocom technology and patient services to its product offerings will expand its reach to more patients across the HF care continuum. Cardiocom also has products for the management of diabetes, cardiovascular disease, and hypertension.
For Medtronic, a company with a lot of investment in the high cost and shrinking-demand market for cardiac rhythm management (CRM) devices, the entrance into patient monitoring is a bid for diversification, helping the company combine diagnostics, therapies, and patient management technologies reporting real-time data back to physicians and nurses. Medtronic has stated that at-home monitoring is a proven method of reducing the rates of hospital readmission, with resulting savings for payers, providers, and governments.
“With broad healthcare reform initiatives focused on growing economic challenges, healthcare systems in every region of the world are striving to continuously improve outcomes, increase access, save cost, and improve the efficiency of healthcare delivery,” said Omar Ishrak, chairman and CEO of Medtronic. “The acquisition of Cardiocom is one step we are taking toward providing a combination of products and solutions that can help address those challenges.”
“The synergy between our technologies and Medtronic's large presence with hospitals, physicians, and payers will dramatically increase our distribution channels for the Cardiocom patient management technologies and services,” said Daniel Cosentino, vice president and general manager of Cardiocom at Medtronic, and former CEO of Cardiocom. “Our approach to care coordination and telehealth services has allowed customers to reduce the overall cost of care, primarily through reduced hospitalizations.”
Related Links:
Medtronic
Cardiocom
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







